4//SEC Filing
Inhibrx, Inc. 4
Accession 0000950170-24-067359
CIK 0002007919operating
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:30 PM ET
Size
5.7 KB
Accession
0000950170-24-067359
Insider Transaction Report
Form 4
Inhibrx, Inc.
10% Owner
Transactions
- Other
Common Stock, par value $0.0001 per share
2024-05-29−13,316,140→ 1,157,926 total
Footnotes (2)
- [F1]On January 8, 2024, Inhibrx, Inc. ("RemainCo"), acquired 100 shares, par value $0.0001 per share (the "Common Stock"), of Inhibrx Biosciences, Inc. (the "Issuer"), which at the time constituted all of the issued and outstanding Common Stock of the Issuer. On May 29, 2024, the Common Stock was split, resulting in RemainCo's ownership of an aggregate 14,474,066 shares of Common Stock of the Issuer.
- [F2]On May 29, 2024 at 11:59 p.m., New York City time, RemainCo distributed approximately 92% of the Common Stock of the Issuer to the holders of record of RemainCo as of May 17, 2024.
Documents
Issuer
Inhibrx Biosciences, Inc.
CIK 0002007919
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001739614
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:30 PM ET
- Size
- 5.7 KB